| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 41 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Rothblatt Martine A | 66.0K | $35.39M | - |
| VP | Mahon Paul A | 44.5K | $23.86M | - |
| CEO | 40.5K | $21.73M | -28,500 | |
| VP | 33.5K | $17.97M | - | |
| CFO | Edgemond James | 19.9K | $10.67M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 8,000 | $414.19 | $3,313,522.60 | -77.0% | +23.9% | - | |
| Sep 19, 2025 | Olian Judy D.60 | Director | Sell | 1,800 | $415.43 | $747,767.88 | -26.3% | +21.4% | - | |
| Sep 18, 2025 | Mahon Paul A47 | EVP &General Counsel | Sale+OE | 11,000 | $406.17 | $4,467,908.11 | -4.2% | +24.7% | - | |
| Sep 18, 2025 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 8,000 | $402.29 | $3,218,352.01 | -64.5% | +24.7% | - | |
| Sep 16, 2025 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 4,000 | $400.27 | $1,601,062.10 | -55.1% | +25.7% | - | |
| Sep 15, 2025 | Benkowitz Michael47 | President And COO | Sale+OE | 22,500 | $400.56 | $9,012,624.13 | -21.9% | +24.1% | - | |
| Sep 15, 2025 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 8,000 | $400.93 | $3,207,435.64 | -52.9% | +24.1% | - | |
| Sep 11, 2025 | Rothblatt Martine A58 | Chairperson &CEO | Sale+OE | 8,000 | $397.97 | $3,183,776.80 | -77.0% | +19.8% | - | |
| Sep 10, 2025 | Thompson Tommy G51 | Director | Sale+OE | 4,560 | $403.36 | $1,839,321.60 | -35.0% | +20.1% | - | |
| Sep 9, 2025 | Malcolm Jan | Director | Sell | 700 | $400.29 | $280,203.00 | -57.4% | +18.7% | - |